All terms in EFO
| Label | Id | Description |
|---|---|---|
| Disease associated with non-acquired combined pituitary hormone deficiency | Orphanet_95495 | |
| response to dietary selenium supplementation | EFO_0600021 | [Physiological response of an organism to being given selenium as a dietary supplement.] |
| selenium | CHEBI_27568 | [A chalcogen that has formula Se.] |
| diplegia of upper limb | MONDO_0004618 | |
| time to remission of COVID-19 symptoms | EFO_0600020 | [Quantification of time to remission of COVID-19 symptoms.] |
| COVID-19 symptoms measurement | EFO_0600019 | [Quantification of some aspect of COVID-19 symptoms, such as severity or time to remission.] |
| obsolete_primary immunodeficiency due to a defect in adaptive immunity | Orphanet_179006 | |
| recurrent hypersomnia | MONDO_0004617 | [Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., idiopathic hypersomnolence; narcolepsy; and kleine-levin syndrome) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, mental disorders, and sleep apnea syndrome). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)] |
| obsolete_Niemann-Pick disease type A | Orphanet_77292 | [Niemann-Pick disease type A is a very severe subtype of Niemann-Pick disease, an autosomal recessive lysosomal disease, and is characterized clinically by onset in infancy or early childhood with failure to thrive, hepatosplenomegaly, and rapidly progressive neurodegenerative disorders.] |
| response to immune checkpoint inhibitor | EFO_0600023 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of immune checkpoint inhibitor stimulus such as Ipilimumab and Anti-PD-1/PD-L1 agents.] |
| obsolete_Niemann-Pick disease type B | Orphanet_77293 | [Niemann-Pick disease type B is a mild subtype of Niemann-Pick disease, an autosomal recessive lysosomal disease, and is characterized clinically by onset in childhood with hepatosplenomegaly, growth retardation, and lung disorders such as infections and dyspnea] |
| response to gamma-aminobutyric acid receptor agonists | EFO_0600022 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma-aminobutyric acid receptor agonist.] |
| gamma-aminobutyric acid | CHEBI_16865 | [A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.] |
| duodenitis | MONDO_0004627 | [Acute or chronic inflammation of the duodenum. Causes include bacterial and viral infections and gastroesophageal reflux disease. Symptoms include vomiting and abdominal pain.] |
| obsolete_pancreatic triacylglycerol lipase deficiency | Orphanet_309031 | |
| Abnormality of refraction | HP_0000539 | [An abnormality in the process of focusing of light by the eye in order to produce a sharp image on the retina.] |
| migraine without aura | MONDO_0100431 | [A migraine disorder characterized by episodes that occur in the absence of preceding focal neurological symptoms.] |
| migraine disorder | MONDO_0005277 | [A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.] |
| obsolete Sparse and thin eyebrow | HP_0000535 | |
| autosomal recessive ataxia due to PEX10 deficiency | MONDO_0016614 |